These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10966023)

  • 21. [Aggressive surgical treatment for cholangiocarcinoma].
    Shimonov M; Schecter P; Avni Y; Rabin E; Rosen A; Czerniak A
    Harefuah; 2001 Jun; 140(6):479-82, 566. PubMed ID: 11420845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
    Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
    Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma.
    Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Shimamura F; Shimizu Y; Miyazaki M
    J Hepatobiliary Pancreat Surg; 2003; 10(4):259-64. PubMed ID: 14598144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surgical treatment for hilar cholangiocarcinoma (Klatskin's tumor)].
    Becker T; Lehner F; Bektas H; Meyer A; Lück R; Nashan B; Klempnauer J
    Zentralbl Chir; 2003 Nov; 128(11):928-35. PubMed ID: 14669113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palliative surgical bypass versus percutaneous transhepatic biliary drainage on unresectable hilar cholangiocarcinoma.
    Wongkonkitsin N; Phugkhem A; Jenwitheesuk K; Saeseow OT; Bhudhisawasdi V
    J Med Assoc Thai; 2006 Nov; 89(11):1890-5. PubMed ID: 17205870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of hilar bile duct carcinoma.
    Bathe OF; Pacheco JT; Ossi PB; Hamilton KL; Franceschi D; Sleeman D; Levi JU; Livingstone AS
    Hepatogastroenterology; 2001; 48(41):1289-94. PubMed ID: 11677948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of surgical approach for extrahepatic cholangiocarcinoma.
    Shi QF; Liang TB; Qin YS; Wang WL; Shen Y; Zhang M; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):622-6. PubMed ID: 18086629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of the relation between surgery and prognosis of hilar cholangiocarcinoma].
    Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Cheng QB; Wu MC
    Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):842-5. PubMed ID: 16083598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palliative surgery for hilar cholangiocarcinoma.
    Li HM; Dou KF; Sun K; Gao ZQ; Li KZ; Fu YC
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):110-3. PubMed ID: 14607660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endoscopic palliative treatment of the common bile duct at the hepatic hilum. Results in 583 patients treated in a single center over a 10-year period].
    De Palma GD; Persico F; Masone S; Labianca O; Mastantuono L; Di Marino M; Persico G
    Minerva Chir; 2003 Apr; 58(2):175-9. PubMed ID: 12738927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas.
    Maire F; Hammel P; Ponsot P; Aubert A; O'Toole D; Hentic O; Levy P; Ruszniewski P
    Am J Gastroenterol; 2006 Apr; 101(4):735-42. PubMed ID: 16635221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
    Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.
    Sano T; Shimada K; Sakamoto Y; Esaki M; Kosuge T
    J Hepatobiliary Pancreat Surg; 2007; 14(5):455-62. PubMed ID: 17909713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An aggressive surgical approach to bile duct cancer.
    Adkins RB; Dunbar LL; McKnight WG; Farringer JL
    Am Surg; 1986 Mar; 52(3):134-9. PubMed ID: 2420244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biliary stent placement for postoperative benign bile duct stenosis: personal experience].
    Sciumè C; Geraci G; Pisello F; Facella T; Li Volsi F; Modica G
    Ann Ital Chir; 2006; 77(1):19-24; discussion 25. PubMed ID: 16910355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palliation for suspected unresectable hilar cholangiocarcinoma.
    Connor S; Barron E; Redhead DN; Ireland H; Madhavan KK; Parks RW; Garden OJ
    Eur J Surg Oncol; 2007 Apr; 33(3):341-5. PubMed ID: 17175127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Main bile duct carcinoma management. Our experience on 38 cases.
    Cavallaro A; Cavallaro V; Di Vita M; Cappellani A
    Ann Ital Chir; 2009; 80(2):107-11. PubMed ID: 19681291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surgical and endoscopic management of bile duct cancer].
    Márton J; Varga L; Géczi T; Farkas G; Balogh A
    Magy Onkol; 2003; 47(4):373-9. PubMed ID: 14716433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Klatskin tumor--results of surgical therapy.
    Zovak M; Doko M; Glavan E; Hochstädter H; Roić G; Ljubicić N
    Coll Antropol; 2004 Jun; 28(1):317-23. PubMed ID: 15636089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.